BenjaminEJBlahaMJChiuveSE, et al.Heart Disease and Stroke Statistics – 2017 update: a report from the American Heart Association. Circulation2017; 135: e146–e603.
2.
ChioncelOMebazaaAHarjolaVP, et al.Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail2017; 19: 1242–1254.
3.
PonikowskiPAnkerSDAlHabibKF, et al.Heart failure: preventing disease and death worldwide. ESC Heart Failure2014; 1: 4–25.
4.
GheorghiadeMVaduganathanMFonarowGC, et al.Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol2013; 61: 391–403.
5.
KievitRFGoharAHoesAW, et al.Queen of Hearts and RECONNECT consortium. Efficient selective screening for heart failure in elderly men and women from the community: a diagnostic individual participant data meta-analysis. Eur J Prev Cardiol2018; 25: 437–446.
6.
SandriMViehmannMAdamsV, et al.Chronic heart failure and aging – effects of exercise training on endothelial function and mechanisms of endothelial regeneration: results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study. Eur J Prev Cardiol2016; 23: 349–358.
7.
VeenisJFBrunner-La RoccaH-PLinssenG, et al.for the CHECK-HF Investigators. Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction. Eur J Prev Cardiol. 2019; 26: 1399–1407.
8.
YancyCWFonarowGCAlbertNM, et al.Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J2009; 157: 754–762.e2.
9.
PulignanoGDel SindacoDTavazziL, et al.Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF registry). Am Heart J2002; 143: 45–55.
10.
KomajdaMFollathFSwedbergK, et al.Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J2003; 24: 464–474.
11.
GreeneSJButlerJAlbertNM, et al.Medical Therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry. J Am Coll Cardiol2018; 72: 351–366.
12.
McMurrayJJAdamopoulosSAnkerSD, et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J2012; 33: 1787–1847.
13.
LundLHBensonLStahlbergM, et al.Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry. Eur J Heart Fail2014; 16: 1073–1081.
14.
FlatcherMDShibataMCCoatsAJ, et al.Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J2005; 26: 215–225.
15.
ElmingMBNielsenJCHaarboJ, et al.Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure. Circulation2017; 136: 1772–1780.
16.
PonikowskiP, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J2016; 37: 2129–2200.
17.
CuthbertJJGopalJCrundall-GoodeA, et al.Are there patients missing from community heart failure registers? An audit of clinical practice. Eur J Prev Cardiol2019; 26: 291–298.
VidánMTSánchezEFernández-AvilésF, et al.FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics. Clin Cardiol2014; 37: 725–732.
20.
VidanMT, et al.Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail2016; 18: 869–875.
21.
KomajdaMCowieMRTavazziL, et al.Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail2017; 19: 1414–1423.
22.
KatsanosSBistolaVParissisJT. Acute heart failure syndromes in the elderly: the European perspective. Heart Fail Clin2015; 11: 637–645.
23.
FlatherMDYusufSKřberL, et al.Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet2000; 355: 1575–1581.
24.
PfefferMASwedbergKGrangerCB, et al.Effect of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme. Lancet2003; 362: 759–766.
25.
RichMW. Pharmacotherapy of heart failure in the elderly: adverse events. Heart Fail Rev2012; 17: 589–595.
26.
ArandaJM JrWooGWContiJB, et al.Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. Am J Cardiol2005; 95: 889–891.
27.
ErmisCZhuAXVanheelL, et al.Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients <75 and patients > or =75 years of age treated with implantable cardioverter defibrillators. Europace2007; 9: 270–274.
